In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Larimar Therapeutics Inc (NASDAQ: LRMR) closed at $3.46 in the last session, down -0.29% from day before closing price of $3.47. In other words, the price has decreased by -$0.29 from its previous closing price. On the day, 1.46 million shares were traded. LRMR stock price reached its highest trading level at $3.475 during the session, while it also had its lowest trading level at $3.215.
Ratios:
We take a closer look at LRMR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.06 and its Current Ratio is at 4.06. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Truist on January 29, 2025, initiated with a Buy rating and assigned the stock a target price of $18.
On October 16, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $26.
On October 03, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $22.Wedbush initiated its Outperform rating on October 03, 2024, with a $22 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 31 ’25 when Flynn James E bought 9,375,000 shares for $3.20 per share. The transaction valued at 30,000,000 led to the insider holds 9,538,945 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LRMR now has a Market Capitalization of 296142752 and an Enterprise Value of 125054760.
Stock Price History:
The Beta on a monthly basis for LRMR is 1.07, which has changed by -0.6275565 over the last 52 weeks, in comparison to a change of 0.12121439 over the same period for the S&P500. Over the past 52 weeks, LRMR has reached a high of $9.50, while it has fallen to a 52-week low of $1.61. The 50-Day Moving Average of the stock is -16.42%, while the 200-Day Moving Average is calculated to be 8.26%.
Shares Statistics:
According to the various share statistics, LRMR traded on average about 2.56M shares per day over the past 3-months and 1649920 shares per day over the past 10 days. A total of 85.59M shares are outstanding, with a floating share count of 48.64M. Insiders hold about 43.17% of the company’s shares, while institutions hold 45.84% stake in the company. Shares short for LRMR as of 1760486400 were 8816753 with a Short Ratio of 3.44, compared to 1757894400 on 7653965. Therefore, it implies a Short% of Shares Outstanding of 8816753 and a Short% of Float of 15.49.
Earnings Estimates
. The current rating of Larimar Therapeutics Inc (LRMR) reflects the combined expertise of 5.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.43, with high estimates of -$0.37 and low estimates of -$0.53.
Analysts are recommending an EPS of between -$1.7 and -$2.18 for the fiscal current year, implying an average EPS of -$1.86. EPS for the following year is -$1.75, with 7.0 analysts recommending between -$1.18 and -$2.54.
